Journal of Urologic Oncology

Previous issues

Page Path

HOME
BROWSE ARTICLES
Previous issue

Volume 19(1); Feb 2021

Review Article

Expert Group Consensus Opinion on Prostate Cancer Diagnosis and Management in India: Part 2 of 2: Amit Ghose, Makarand Khochikar, Ravindra Sabnis, Naveen Magendra Parmar, Indranil Purkait; Korean J Urol Oncol. 2021;19(1):1-15. Published online February 26, 2021; DOI: https://doi.org/10.22465/kjuo.2021.19.1.1; Full text PubReader ePub PDF

Review Article

Coffee Consumption and Risk of Prostate Cancer in Local, Advanced, and Fatal Grades: A Meta-Epidemiological Study of Prospective Cohort Studies: Jong-Myon Bae; Korean J Urol Oncol. 2021;19(1):16-22. Published online February 26, 2021; DOI: https://doi.org/10.22465/kjuo.2021.19.1.16; Full text PubReader ePub PDF

Review Article

Understanding Cancer Pain and Controlling Pain: Focusing on Patients With Metastatic Urologic Cancer: Jaemin Jo, Sanghoon Han, Jung-Sik Huh; Korean J Urol Oncol. 2021;19(1):23-29. Published online February 26, 2021; DOI: https://doi.org/10.22465/kjuo.2021.19.1.23
Cited By 2; Full text PubReader ePub PDF

Review Article

The Development of Antibody-Drug Conjugates for Urothelial Carcinoma Treatment: Da Som Choi, Su Jeong Kang, In Ho Chang, Young Wook Choi; Korean J Urol Oncol. 2021;19(1):30-39. Published online February 26, 2021; DOI: https://doi.org/10.22465/kjuo.2021.19.1.30; Full text PubReader ePub PDF

Original Article

The Effects of Recombinant Bacillus Calmette-Guérin Resistant to Antimicrobial Peptides on Orthotopic Bladder Cancer Mouse Model: Seok Ju Hong, Gwang Yong Hwang, Su Jeong Kang, Se Young Choi, Byung Hoon Chi, In Ho Chang; Korean J Urol Oncol. 2021;19(1):40-47. Published online February 26, 2021; DOI: https://doi.org/10.22465/kjuo.2021.19.1.40
Cited By 1; Full text PubReader ePub PDF

Original Article

The Real-World Experience of Single-Center, Retrospective Study of the Prognostic Effect of Secondary Hormone Agent on Survival in Patients With Hormone-Refractory Metastatic Prostate Cancer: Sung Han Kim, Done-Eun Lee, Ho Kyung Seo, Jinsoo Chung, Jae Young Joung; Korean J Urol Oncol. 2021;19(1):48-59. Published online February 26, 2021; DOI: https://doi.org/10.22465/kjuo.2021.19.1.48; Full text PubReader ePub PDF Supplementary Material

Original Article

Serum Testosterone Level as Possible Predictive Marker for Prognosis in Metastatic Castration-Resistant Prostate Cancer Patients Treated With Enzalutamide: Dong Hyeon An, Hwiwoo Kim, Donghyun Lee, In Gab Jeong, Dalsan You, Jun Hyuk Hong, Choung-Soo Kim, Hanjong Ahn; Korean J Urol Oncol. 2021;19(1):60-69. Published online February 26, 2021; DOI: https://doi.org/10.22465/kjuo.2021.19.1.60; Full text PubReader ePub PDF

Journal of
Urologic Oncology

Print ISSN: 2951-603X
Online ISSN: 2982-7043

MOST READ MOST CITED

5,578	New Drugs for Bacillus Calmette Guérin-Unresponsive Nonmuscle Invasive Bladder Cancer
5,029	The Important Role of Poly ADP-Ribose Polymerase Inhibitor in Prostate Cancer
4,371	The Present and Future of Intravesical Therapy in Bladder Cancer
4,321	An Update of Prostate-Specific Membrane Antigen Theranostics in Prostate Cancer
4,296	Complex Epidemiology of Prostate Cancer in Asian Countries

Cited By 7	Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades
Cited By 4	An Update of Prostate-Specific Membrane Antigen Theranostics in Prostate Cancer
Cited By 4	Complex Epidemiology of Prostate Cancer in Asian Countries
Cited By 3	The Evolving Role of Checkpoint Inhibitors in the Treatment of Urothelial Carcinoma: A Literature Review of Practice-Changing Trials
Cited By 2	Prostate Imaging and Reporting and Data System Version 2.1: Limitations for Clinical Use

Editorial Office: Department of Urology, Seoul National University Hospital, Seoul National University College of Medicine,
101 Daehak-ro, Jongno-gu, Seoul 03080, Korea
TEL: +82-2-2072-0817, FAX: +82-2-742-4665 Email: journal@e-juo.org

Korean Urological Oncology Society
50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
Tel: +82-2-704-8574, E-mail: kspe.editor@gmail.com

Copyright © The Korean Urological Oncology Society.